NKA Pharm Limited

Registered Number
15698378
(England and Wales)

Unaudited Financial Statements for the Period ended
31 May 2025

NKA Pharm Limited

Company Information
for the period from 1 May 2024 to 31 May 2025


Director	Y Agyako


Registered Number	15698378 (England and Wales)

NKA Pharm Limited

Balance Sheet as at
31 May 2025

		2025 £

Fixed Assets		50,366

Current Assets		9,727
Creditors amounts falling due within one year		(33,379)
Net current assets (liabilities)		(23,652)

Total assets less current liabilities		26,714

Net assets (liabilities)		26,714
Capital and reserves		26,714

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 0.

The financial statements were approved and authorised for issue by the Director on 25 November 2025, and are signed on its behalf by:

Y Agyako
Director
Registered Company No. 15698378